HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Eric W. Young Marvin M. Kirsh Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Young, E. W. Articles by Kirsh, M. M. Search for Related Content PubMed PubMed Citation Articles by Young, E. W. Articles by Kirsh, M. M.

Ann Thorac Surg 1998;65:1316-1319
© 1998 The Society of Thoracic Surgeons

Intravenous Diltiazem and Acute Renal Failure After Cardiac Operations

^a Nephrology and Cardiothoracic Surgery Sections, Veterans Affairs Medical Center and University of Michigan Medical School, Ann Arbor, Michigan, USA

Accepted for publication December 18, 1997.

Address reprint requests to Dr Young, Nephrology Section (111-J), VA Medical Center, 2215 Fuller Rd, Ann Arbor, MI 48105

Background. Perioperative administration of intravenous diltiazem to patients undergoing cardiac procedures has been shown to decrease the incidence of ischemia and arrhythmias. However, after adopting this practice in our cardiac surgery program, we perceived an increased incidence of postoperative renal dysfunction.

Methods. A directed record review of postoperative renal function was conducted for consecutive patients undergoing cardiac operation for the time periods before and after adoption of prophylactic intravenous diltiazem (0.1 mg · kg^-1 · h^-1 for 24 hours). The two groups were compared using ² and two-sample t tests. The risk of development of postoperative renal failure was modeled with logistic regression.

Results. Diltiazem-treated patients (n = 271) were similar to the control patients (n = 143) in terms of age (64 versus 61 years; p = 0.14), ejection fraction (0.46 versus 0.47; p = 0.61), baseline serum creatinine level (1.2 versus 1.1 mg/dL; p = 0.27), prevalence of comorbid conditions, and surgical characteristics. The prevalence of left main coronary artery disease was lower in the diltiazem group than the control group (39% versus 52%; p = 0.01). During the 7-day postoperative period, the average peak serum creatinine level was higher in the diltiazem group (1.7 ± 0.9 mg/dL; mean ± 1 standard deviation) than the control group (1.5 ± 0.5 mg/dL; p = 0.003). The incidence of acute renal failure requiring dialysis was 4.4% in the diltiazem group versus 0.7% in the control group (p = 0.04). There was no difference in length of hospitalization or mortality. The risk of acute renal failure was strongly associated with intravenous diltiazem (adjusted odds ratio [AOR] 6.3; p = 0.08), age (AOR 2.5 per 10 years; p = 0.07), baseline serum creatinine (AOR 4.8 per 1 mg/dL; p = 0.02), the presence of left main coronary disease (AOR 5.3; p = 0.02), and the presence of cerebrovascular disease (AOR 4.5; p = 0.05).

Conclusions. Our retrospective analysis suggests that prophylactic use of intravenous diltiazem in patients undergoing cardiac operations was associated with increased renal dysfunction. Further studies of the risk and benefits of intravenous diltiazem in this setting should be undertaken.

This article has been cited by other articles:

				M. H. Rosner, D. Portilla, and M. D. Okusa Analytic Reviews: Cardiac Surgery as a Cause of Acute Kidney Injury: Pathogenesis and Potential Therapies J Intensive Care Med, January 1, 2008; 23(1): 3 - 18. [Abstract] [PDF]

				M. H. Rosner and M. D. Okusa Acute Kidney Injury Associated with Cardiac Surgery Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 19 - 32. [Abstract] [Full Text] [PDF]

				S. Manabe, H. Tanaka, T. Yoshizaki, N. Tabuchi, H. Arai, and M. Sunamori Effects of the Postoperative Administration of Diltiazem on Renal Function After Coronary Artery Bypass Grafting Ann. Thorac. Surg., March 1, 2005; 79(3): 831 - 835. [Abstract] [Full Text] [PDF]

				D. Amar and M. Fleisher Diltiazem Treatment Does Not Alter Renal Function After Thoracic Surgery Chest, May 1, 2001; 119(5): 1476 - 1479. [Abstract] [Full Text] [PDF]

				C. L. DAVIS, A. T. KAUSZ, R. A. ZAGER, E. D. KHARASCH, and R. P. COCHRAN Acute Renal Failure after Cardiopulmonary Bypass Is Related to Decreased Serum Ferritin Levels J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2396 - 2402. [Abstract] [Full Text]